Carregant...
The radiosensitizer Onalespib increases complete remission in (177)Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts
PURPOSE: (177)Lu-DOTATATE targeting the somatostatin receptor (SSTR) is utilized for treatment of neuroendocrine tumors (NETs). Onalespib, a heat shock protein 90 (HSP90) inhibitor, has demonstrated radiosensitizing properties and may thus enhance the effect of (177)Lu-DOTATATE. Consequently, the ai...
Guardat en:
| Publicat a: | Eur J Nucl Med Mol Imaging |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7075859/ https://ncbi.nlm.nih.gov/pubmed/31912256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-019-04673-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|